Skip to main content
NVDA+1.08%AAPL+0.05%GOOGL+0.86%MSFT+0.95%AMZN+0.83%TSM+2.75%SPCX+7.63%META+0.38%AVGO+2.08%TSLA+0.99%SKHY-0.06%MU+0.15%BRK-B+0.32%LLY+0.02%AMD-0.34%JPM0.00%WMT+0.78%ASMLa+0.74%V+2.51%XOM+0.01%JNJ-1.21%INTC-2.63%0700.HK+1.23%MA+2.23%ABBV+1.12%1398.HK+1.61%CSCO+0.55%LRCX-0.49%AP2d+1.23%AMAT+0.41%CVX-0.11%ORCL+0.18%COST+0.31%CAT+0.32%BAC+0.47%KO+1.00%DELL-1.86%PG+0.71%UNH+1.80%0005.HK+1.93%HSBA.L+0.93%3988.HK+1.69%ARM-1.49%1816.HK+0.48%GE-1.04%0857.HK+1.04%MS-0.06%0939.HK+1.47%PM+1.10%1288.HK+0.92%PLNJPY+0.83%USDZAR-0.79%USDPLN-0.79%USDMXN-0.71%AUDCHF+0.66%USDSEK-0.61%CHFSEK-0.54%AUDJPY+0.53%GBPCHF+0.46%EURHKD+0.45%USDDKK-0.43%GBPTRY+0.41%AUDUSD+0.40%EURCNH+0.38%AUDCAD+0.37%NZDMXN-0.36%GBPZAR-0.36%GBPJPY+0.36%EURPLN-0.35%EURZAR-0.35%NOKJPY+0.35%GBPHKD+0.32%AUDNZD+0.32%USDNOK-0.32%EURCHF+0.32%GBPUSD+0.29%GBPMXN-0.28%NZDCHF+0.27%GBPCAD+0.26%EURSGD+0.26%AUDDKK-0.26%EURAUD-0.25%GBPSGD+0.25%CHFNOK-0.24%EURJPY+0.21%GBPNZD+0.20%CADCHF+0.20%SGDJPY+0.20%EURCZK-0.19%NZDSGD+0.18%USDCHF+0.18%EURSEK-0.17%USDSGD-0.17%NZDJPY+0.17%USDILS+0.16%GBPAUD-0.15%AUDNOK-0.15%EURUSD+0.15%EURGBP-0.13%EURNOK+0.12%EURCAD+0.12%CHFJPY-0.11%CHFSGD-0.11%USDTRY+0.11%CADJPY+0.10%USDJPY+0.09%NZDUSD+0.08%EURNZD+0.07%USDTHB+0.07%NZDCAD+0.06%USDCNH-0.05%USDCOP-0.04%USDCAD-0.02%EURDKK+0.01%USDHKD+0.01%AUDSGD0.00%UKOIL-2.40%USOIL-1.98%COCOA-1.17%W1+1.14%C1+0.85%GAUUSD+0.82%XAUUSD+0.82%COFFEE+0.70%COTTON+0.69%XNGUSD+0.69%GAGUSD+0.68%XAGUSD+0.68%BTCUSD+0.62%ETHUSD+6.15%USDTUSD-0.03%XRPUSD-0.54%SOLUSD-2.00%TRXUSDT-0.18%ZECUSDT+2.32%DOGEUSD-1.82%XMRUSDT-0.78%LINKUSD+3.21%XLMUSD+0.42%BCHUSDT+0.38%UNIUSD-2.02%LTCUSD-4.60%SUIUSD-0.93%HBARUSDT-0.24%TONUSD+12.52%TAOUSDT-0.52%AAVEUSD-0.90%DOTUSDT+0.44%ICPUSDT-3.81%ONDOUSDT+0.18%WLDUSDT+0.82%ARBUSDT-3.14%JUPUSDT-0.14%ATOMUSDT-0.52%INJUSDT+0.85%STXUSDT+0.08%FETUSDT-1.70%SEIUSDT-0.61%PYTHUSDT+1.03%TIAUSDT-1.42%IMXUSDT-1.75%GRTUSDT-0.21%OPUSDT-2.99%WIFUSDT+0.40%IOTAUSDT+3.76%AXSUSDT-0.90%POLUSDT+1.55%FARTCOINUSDT+2.25%EOSUSDT+3.39%DYDXUSDT-1.74%GALAUSDT-0.52%ORDIUSDT+1.05%NOTUSDT+1.29%RONINUSDT+4.44%NVDA+1.08%AAPL+0.05%GOOGL+0.86%MSFT+0.95%AMZN+0.83%TSM+2.75%SPCX+7.63%META+0.38%AVGO+2.08%TSLA+0.99%SKHY-0.06%MU+0.15%BRK-B+0.32%LLY+0.02%AMD-0.34%JPM0.00%WMT+0.78%ASMLa+0.74%V+2.51%XOM+0.01%JNJ-1.21%INTC-2.63%0700.HK+1.23%MA+2.23%ABBV+1.12%1398.HK+1.61%CSCO+0.55%LRCX-0.49%AP2d+1.23%AMAT+0.41%CVX-0.11%ORCL+0.18%COST+0.31%CAT+0.32%BAC+0.47%KO+1.00%DELL-1.86%PG+0.71%UNH+1.80%0005.HK+1.93%HSBA.L+0.93%3988.HK+1.69%ARM-1.49%1816.HK+0.48%GE-1.04%0857.HK+1.04%MS-0.06%0939.HK+1.47%PM+1.10%1288.HK+0.92%PLNJPY+0.83%USDZAR-0.79%USDPLN-0.79%USDMXN-0.71%AUDCHF+0.66%USDSEK-0.61%CHFSEK-0.54%AUDJPY+0.53%GBPCHF+0.46%EURHKD+0.45%USDDKK-0.43%GBPTRY+0.41%AUDUSD+0.40%EURCNH+0.38%AUDCAD+0.37%NZDMXN-0.36%GBPZAR-0.36%GBPJPY+0.36%EURPLN-0.35%EURZAR-0.35%NOKJPY+0.35%GBPHKD+0.32%AUDNZD+0.32%USDNOK-0.32%EURCHF+0.32%GBPUSD+0.29%GBPMXN-0.28%NZDCHF+0.27%GBPCAD+0.26%EURSGD+0.26%AUDDKK-0.26%EURAUD-0.25%GBPSGD+0.25%CHFNOK-0.24%EURJPY+0.21%GBPNZD+0.20%CADCHF+0.20%SGDJPY+0.20%EURCZK-0.19%NZDSGD+0.18%USDCHF+0.18%EURSEK-0.17%USDSGD-0.17%NZDJPY+0.17%USDILS+0.16%GBPAUD-0.15%AUDNOK-0.15%EURUSD+0.15%EURGBP-0.13%EURNOK+0.12%EURCAD+0.12%CHFJPY-0.11%CHFSGD-0.11%USDTRY+0.11%CADJPY+0.10%USDJPY+0.09%NZDUSD+0.08%EURNZD+0.07%USDTHB+0.07%NZDCAD+0.06%USDCNH-0.05%USDCOP-0.04%USDCAD-0.02%EURDKK+0.01%USDHKD+0.01%AUDSGD0.00%UKOIL-2.40%USOIL-1.98%COCOA-1.17%W1+1.14%C1+0.85%GAUUSD+0.82%XAUUSD+0.82%COFFEE+0.70%COTTON+0.69%XNGUSD+0.69%GAGUSD+0.68%XAGUSD+0.68%BTCUSD+0.62%ETHUSD+6.15%USDTUSD-0.03%XRPUSD-0.54%SOLUSD-2.00%TRXUSDT-0.18%ZECUSDT+2.32%DOGEUSD-1.82%XMRUSDT-0.78%LINKUSD+3.21%XLMUSD+0.42%BCHUSDT+0.38%UNIUSD-2.02%LTCUSD-4.60%SUIUSD-0.93%HBARUSDT-0.24%TONUSD+12.52%TAOUSDT-0.52%AAVEUSD-0.90%DOTUSDT+0.44%ICPUSDT-3.81%ONDOUSDT+0.18%WLDUSDT+0.82%ARBUSDT-3.14%JUPUSDT-0.14%ATOMUSDT-0.52%INJUSDT+0.85%STXUSDT+0.08%FETUSDT-1.70%SEIUSDT-0.61%PYTHUSDT+1.03%TIAUSDT-1.42%IMXUSDT-1.75%GRTUSDT-0.21%OPUSDT-2.99%WIFUSDT+0.40%IOTAUSDT+3.76%AXSUSDT-0.90%POLUSDT+1.55%FARTCOINUSDT+2.25%EOSUSDT+3.39%DYDXUSDT-1.74%GALAUSDT-0.52%ORDIUSDT+1.05%NOTUSDT+1.29%RONINUSDT+4.44%
MA

MannKind Corporation (MNKD)

NASDAQ • Healthcare

$3.82
+$0.02 (+0.5%)
Market closed

Last close at October 5, 2026 at 20:00 UTC

Open$3.82
Day Range$3.7 - $3.85
Avg. Volume (3M)5.2M
Market Cap$1.2B
52 Week Range
$2.23$6.51
Next EarningsIn 29 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$109.3M100%
Gross Profitminus cost of goods$79.8M73%

In plain terms: out of every $100 in revenue, MannKind Corporation currently loses $17.

Fundamentals & Financials

Revenue (TTM)
$393.6M
Net Income (TTM)
-$43.6M
EPS (TTM)
-$0.14
ROA (TTM)
-5.96%
Current Ratio
1.72

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-400.0%Q1 2026-$0.05
-150.0%Q2 2026-$0.05
-700.0%Q3 2026-$0.06
Next

Nov 4

in 29 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Next report — what to expect

MannKind Corporation (MNKD) reports on November 4, 2026. Wall Street expects EPS of -$0.08 on revenue of $110.3 million. For trailing context, revenue grew +42.9% year over year last quarter. MannKind has beaten EPS in 2 of its 8 most recent quarters, so focus on update drivers versus consensus.

View full earnings history

About MannKind Corporation

MannKind Corporation develops and commercializes respiratory-delivered therapies in biotechnology and trades on the NASDAQ under MNKD. Its work centers on endocrine and pulmonary drug products, led by Afrezza and Thyquidity, and it generated $349.0 million of revenue in FY2025 from marketed therapies and development-stage programs.

Name
MannKind Corporation
CEO
Michael E. Castagna
Website
www.mannkindcorp.com
Industry
Healthcare
Year Founded
1991
Employees
592

Today's Snapshot

AI-generated

The day ended with MNKD 0.5% higher at 3.82, in line with a firmer sector. Trading was lighter than usual, with volume about two-fifths of its usual level. MannKind reported 43% revenue growth while still posting losses.

Trading Volume

Below 10d avg (6.8M)

2.6M

vs S&P 500 Today

Moderate Underperformance

-0.23%

Updated: October 5, 2026 at 20:24 UTC

MNKD Headlines

FDA clears Afrezza pediatric use

May 29, 2026

3 min read
View All News

Technical Indicators

4 Buy3 Neutral1 Sell
MNKD presents a cautiously constructive setup with mixed trend cues and mild positive momentum. ADX near 23 suggests only modest directional conviction while RSI and stochastic are neutral, and MACD is essentially flat; shorter-term averages sit below price and the 10/20 EMAs are slightly supportive whereas the 50- and 200-day averages remain overhead, creating mixed moving-average structure. ATR implies moderate intraday range and OBV is deeply negative numerically despite a buy flag, indicating uneven volume support. Technical takeaway: buy — short-term bias favors upside but trend and volume are mixed.
All signals
  • EMA (5 indicators)$3.67 - $4.16
    Buy
  • RSI (14)54.03
    Neutral
  • Stochastic %K (14, 3, 3)65.40
    Neutral
  • MACD Level (12, 26)-0.05
    Neutral

Peers & Related Assets

HRMYHarmony Biosciences Holdings, Inc.
$39.92+0.7%
CLDXCelldex Therapeutics, Inc.
$32.59+3.0%
VERAVera Therapeutics, Inc.
$29.83-1.9%
AUPHAurinia Pharmaceuticals Inc.
$15.72-0.7%
BHVNBiohaven Ltd.
$12.97+0.8%
NUVBNuvation Bio Inc.
$4.95-3.7%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.